AtriCure, a firm based outside of Cincinnati, Ohio, is now making available in the United States its AtriClip PRO•V Left Atrial Appendage (LAA) Exclusion System. The device, used to occlude the LAA as necessitated by other open heart procedures, received FDA clearance in March of 2016.
The LAA is a cul-de-sac where blood experiences quite a bit of (Read more...)